Genesco
GCO
172 hedge funds and large institutions have $1.28B invested in Genesco in 2016 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 59 reducing their positions, and 24 closing their positions.
21% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 24
17% more capital invested
Capital invested by funds: $1.1B → $1.28B (+$187M)
5.73% more ownership
Funds ownership: 98.24% → 103.97% (+5.7%)
2% more funds holding
Funds holding: 169 → 172 (+3)
7% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 59
21% less call options, than puts
Call options by funds: $1.74M | Put options by funds: $2.2M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
-$19.9M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$14.4M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$9.05M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.9M |
| 5 |
Two Sigma Advisers
New York
|
-$3.35M |
GCO Hedge Fund Activity: Q4 2016 in Review
172 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Genesco (GCO) for Q4 2016, worth a combined $1.28B — up 17% from $1.1B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new GCO positions and 24 closed out — a net gain of 5 holders — while 63 added to existing stakes and 59 trimmed.
The largest buyer was Ameriprise, adding an estimated $17.4M. The largest seller was Royce & Associates, cutting an estimated $19.9M.
- 172 institutional investors held Genesco (GCO) as of Q4 2016, up from 169 in Q3 2016.
- Funds reported $1.28B of Genesco stock for Q4 2016, up 17% quarter-over-quarter.
- 29 funds opened new Genesco positions in Q4 2016 and 24 closed out, a net change of +5 holders.
- The largest Genesco buyer in Q4 2016 was Ameriprise, an estimated $17.4M added.
- The largest Genesco seller in Q4 2016 was Royce & Associates, an estimated $19.9M sold.
Based on aggregated 13F filings for Q4 2016.